Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Defence Science and Technology Laboratory

Home Clinical Trial Sponsors and OrganizationsDefence Science and Technology Laboratory

Defence Science and Technology Laboratory

Porton Down, Salisbury, United Kingdom

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

5

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

3

60.0%

Not Applicable

1

20.0%

Phase 2

1

20.0%

Trial Status Distribution

Completed

5

100.0%

Clinical Trials

Trials sponsored by this organization (5)

A programme to develop a skin patch containing two medicines (physostigmine and hyoscine), Study 8: Assessment of effects of consecutive 24-hour applications of patches for 21 days on the blood levels of the two medicines and any associated symptoms in healthy male and female participants

Jun 202154 participants

A programme to develop a skin patch containing two medicines (physostigmine and hyoscine), Study 7: Assessment of effects of an armband covering the skin patch on the blood levels of the two medicines and any associated symptoms in healthy male participants

Jan 202131 participants

A study of the blood levels of physostigmine and hyoscine and associated symptoms following intravenous administration in healthy male and female participants.

Nov 202032 participants

The pre-symptomatic detection of early extreme response to an infection (sepsis)

Oct 20204,385 participants

A programme to develop a skin patch containing two medicines (physostigmine and hyoscine), study 5: Assessment of blood levels of the two medicines and any associated symptoms in healthy male participants

Jan 202030 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials5
Approvals
News

Back to Organizations